close
References
  1. Hampel H, de la Chapelle A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev Res (Phila). 2011;4(1):1-5.
  2. Møller P, Seppälä T, Bernstein I, et al; Mallorca Group. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66(3):464-472.
  3. Committee on Practice Bulletins-Gynecology; Society of Gynecologic Oncology. ACOG Practice Bulletin No. 147: Lynch syndrome. Obstet Gynecol. 2014;124(5):1042-1054.
  4. SGO Clinical Practice Statement: Screening for Lynch Syndrome in Endometrial Cancer. 2014. www.sgo.org/clinical-practice/guidelines/screening-for-lynch-syndrome-in-endometrial-cancer.
  5. Meyer LA, Broaddus RR, Lu KH. Endometrial cancer and Lynch syndrome: clinical and pathologic considerations. Cancer Control. 2009;16(1):14-22.
  6. Ryan NAJ, Evans DG, Green K, Crosbie EJ. Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer. Gynecol Oncol. 2017;144(3):491-495.
  7. Wolf AI, Buchanan AH, Farkas LM. Historical review of Lynch syndrome. J Coloproctol (Rio J). 2013;33(2):95-110.
  8. US Preventive Services Task Force, Grossman DC, Curry SJ, et al. Screening for ovarian cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319(6):588-594.